Screener
Artiva Biotherapeutics, Inc. ARTV Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s return on equity?
- Artiva Biotherapeutics, Inc. (ARTV) reported return on equity of -36.6% in Q2 2026.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Artiva Biotherapeutics, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude